Dr. Kendra M. Harris
Claim this profileTulane University Health Sciences Center
Studies Cancer
Studies Adenocarcinoma
11 reported clinical trials
35 drugs studied
Area of expertise
1Cancer
p16 negative
EGFR positive
EGFR negative
2Adenocarcinoma
MMR negative
MMR positive
ARID1A positive
Affiliated Hospitals
Clinical Trials Kendra M. Harris is currently running
Digital Tomosynthesis vs. Standard Mammography
for Breast Cancer Screening
This randomized phase III trial studies digital tomosynthesis mammography and digital mammography in screening patients for breast cancer. Screening for breast cancer with tomosynthesis mammography may be superior to digital mammography for breast cancer screening and may help reduce the need for additional imaging or treatment.
Recruiting2 awards Phase 34 criteria
Chemotherapy + Radiation Therapy
for Head and Neck Cancer
This phase II/III trial studies how well radiation therapy works when given together with cisplatin, docetaxel, cetuximab, and/or atezolizumab after surgery in treating patients with high-risk stage III-IV head and neck cancer the begins in the thin, flat cells (squamous cell). Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. Drugs used in chemotherapy, such as cisplatin and docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Cetuximab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. The purpose of this study is to compare the usual treatment (radiation therapy with cisplatin chemotherapy) to using radiation therapy with docetaxel and cetuximab chemotherapy, and using the usual treatment plus an immunotherapy drug, atezolizumab.
Recruiting1 award Phase 2 & 321 criteria
More about Kendra M. Harris
Clinical Trial Related6 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Kendra M. Harris has experience with
- Biospecimen Collection
- Atezolizumab
- Apalutamide
- Data Collection
- Quality-of-Life Assessment
- Questionnaire Administration
Breakdown of trials Kendra M. Harris has run
Cancer
Adenocarcinoma
Prostate Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kendra M. Harris specialize in?
Kendra M. Harris focuses on Cancer and Adenocarcinoma. In particular, much of their work with Cancer has involved p16 negative patients, or patients who are EGFR positive.
Is Kendra M. Harris currently recruiting for clinical trials?
Yes, Kendra M. Harris is currently recruiting for 6 clinical trials in New Orleans Louisiana. If you're interested in participating, you should apply.
Are there any treatments that Kendra M. Harris has studied deeply?
Yes, Kendra M. Harris has studied treatments such as Biospecimen Collection, Atezolizumab, Apalutamide.
What is the best way to schedule an appointment with Kendra M. Harris?
Apply for one of the trials that Kendra M. Harris is conducting.
What is the office address of Kendra M. Harris?
The office of Kendra M. Harris is located at: Tulane University Health Sciences Center, New Orleans, Louisiana 70112 United States. This is the address for their practice at the Tulane University Health Sciences Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.